SCHEDULE 13G/A: T. Rowe Price Investment Management Discloses 17.1% Stake in Revvity Inc.

T. Rowe Price Investment Management, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 17.1% of Revvity Inc.'s common stock as of December 31, 2024.

Summary

• T. Rowe Price Investment Management, Inc. reported beneficial ownership of 20,763,083 shares of Revvity Inc. common stock.
• This represents 17.1% of Revvity Inc.'s common stock outstanding.
• The filing indicates that T. Rowe Price Investment Management, Inc. holds sole voting power over 19,415,502 shares and sole dispositive power over 20,762,808 shares.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
• T. Rowe Price Capital Appreciation Fund, advised by T. Rowe Price Investment Management, Inc., holds 13,158,721 shares, accounting for 10.8% of the class.

Sentiment

Score: 7

Explanation: The filing indicates a substantial and passive investment by a highly respected asset manager, T. Rowe Price Investment Management, Inc., in Revvity Inc. This significant stake (17.1%) suggests a strong belief in the company's long-term prospects from a major institutional investor, which can be viewed positively by the market.

Positives

• A significant stake (17.1%) held by a reputable investment firm like T. Rowe Price Investment Management, Inc. can be viewed as a vote of confidence in Revvity Inc.
• The filing explicitly states that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control, suggesting a long-term investment perspective rather than an activist one.

Management Comments

• "T. Rowe Price Investment Management, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Investment Management is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied."
• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11."

Industry Context

This filing indicates a significant institutional investment in Revvity Inc., a company likely operating in the life sciences, diagnostics, or analytical instruments sector, given its name and typical investor interest. Such large stakes by major asset managers like T. Rowe Price are common in the investment landscape, reflecting their portfolio allocation strategies and confidence in specific companies within their target industries.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by a major institutional investor like T. Rowe Price may instill confidence among existing shareholders and attract new investors, potentially influencing stock price positively.
• Management: Management may view this as a validation of their strategy, though the filing explicitly states the investment is not for control purposes.

Key Dates

Keywords

Revvity Inc., T. Rowe Price Investment Management, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Equity Stake, Investment Management, Public Filings